Privacy preference

MEDtalks would like to keep you informed about the content that is most relevant to you. Click here for more information.

POST ESMO-EHA / Multiple Myeloma

Published on: 25.09.2020, 21 min.

In this presentation, Carmen De Ramon Ortiz, HUG, Geneva covers the most important findings from the EHA virtual meeting 2020 for the topic Multiple Myeloma.


Her mentor for this presentation was Prof. Dr. med. Gabriela Baerlocher.


Immune therapies

  • CAR-T:bb2121 (KarMMa)
  • Bi-specific antibody: Teclistamab
  • Antibody/drug conjugate: DREAMM-6


Trial updates

  • Swog-1211
  • Ikema
  • Tourmaliine-MM44


return to overview

  • Sponsors

    This program is editorially independent and is financially supported by: